Excedrin Migraine Caplets Recalled Due to Improper Storage Conditions
Family Dollar Stores is recalling Excedrin Migraine Caplets (24 CT) due to improper storage temperature conditions that may affect product quality. Affected products were distributed nationwide between April 30 and June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for a manufacturing deviation (improper storage conditions) with no reported illnesses or injuries. The recall addresses a precautionary concern about product quality rather than confirmed safety harm.
Plain-English summary
Family Dollar Stores, Llc. is recalling Excedrin Migraine Caplet 24 CT packages due to Current Good Manufacturing Practice (CGMP) deviations. The recalled products were held outside appropriate storage temperature conditions, which may compromise product quality and potency.
The affected products were distributed nationwide through specific Family Dollar Stores between April 30, 2022 and June 10, 2022. The SKU for the recalled product is 913722.
The recalled product
- Product
- EXCEDRIN MIGRAINE CAPLET 24 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 913722
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27